These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18702701)

  • 1. Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity.
    Forster GL; Pringle RB; Mouw NJ; Vuong SM; Watt MJ; Burke AR; Lowry CA; Summers CH; Renner KJ
    Eur J Neurosci; 2008 Jul; 28(2):299-310. PubMed ID: 18702701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens.
    Lukkes JL; Forster GL; Renner KJ; Summers CH
    Eur J Pharmacol; 2008 Jan; 578(2-3):185-93. PubMed ID: 17945210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala.
    Scholl JL; Vuong SM; Forster GL
    Eur J Pharmacol; 2010 Oct; 644(1-3):80-7. PubMed ID: 20655906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of corticotropin releasing factor.
    Nazzaro C; Marino S; Barbieri M; Siniscalchi A
    Neurochem Int; 2009; 54(5-6):378-84. PubMed ID: 19418633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.
    Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
    Psychopharmacology (Berl); 2012 Apr; 220(3):599-610. PubMed ID: 21947356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.
    Kirby LG; Rice KC; Valentino RJ
    Neuropsychopharmacology; 2000 Feb; 22(2):148-62. PubMed ID: 10649828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.
    Pernar L; Curtis AL; Vale WW; Rivier JE; Valentino RJ
    J Neurosci; 2004 Feb; 24(6):1305-11. PubMed ID: 14960601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor.
    Ohmura Y; Izumi T; Yamaguchi T; Tsutsui-Kimura I; Yoshida T; Yoshioka M
    Neuropsychopharmacology; 2010 May; 35(6):1271-8. PubMed ID: 20072117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior.
    Forster GL; Feng N; Watt MJ; Korzan WJ; Mouw NJ; Summers CH; Renner KJ
    Neuroscience; 2006 Aug; 141(2):1047-1055. PubMed ID: 16713119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety states induced by post-weaning social isolation are mediated by CRF receptors in the dorsal raphe nucleus.
    Bledsoe AC; Oliver KM; Scholl JL; Forster GL
    Brain Res Bull; 2011 May; 85(3-4):117-22. PubMed ID: 21396988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.
    Hwa LS; Shimamoto A; Kayyali T; Norman KJ; Valentino RJ; DeBold JF; Miczek KA
    Addict Biol; 2016 Jan; 21(1):111-24. PubMed ID: 25262980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors.
    Mo B; Feng N; Renner K; Forster G
    Brain Res Bull; 2008 Jul; 76(5):493-8. PubMed ID: 18534257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.
    Price ML; Lucki I
    J Neurosci; 2001 Apr; 21(8):2833-41. PubMed ID: 11306635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
    Staub DR; Evans AK; Lowry CA
    Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoaminergic activity in subregions of raphé nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor.
    Summers CH; Kampshoff JL; Ronan PJ; Lowry CA; Prestbo AA; Korzan WJ; Renner KJ
    J Neuroendocrinol; 2003 Dec; 15(12):1122-33. PubMed ID: 14636174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat.
    Hajós M; Richards CD; Székely AD; Sharp T
    Neuroscience; 1998 Nov; 87(1):95-108. PubMed ID: 9722144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of corticotropin-releasing factor on brain serotonergic activity.
    Price ML; Curtis AL; Kirby LG; Valentino RJ; Lucki I
    Neuropsychopharmacology; 1998 Jun; 18(6):492-502. PubMed ID: 9571657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons.
    Kirby LG; Freeman-Daniels E; Lemos JC; Nunan JD; Lamy C; Akanwa A; Beck SG
    J Neurosci; 2008 Nov; 28(48):12927-37. PubMed ID: 19036986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system.
    Lowry CA; Rodda JE; Lightman SL; Ingram CD
    J Neurosci; 2000 Oct; 20(20):7728-36. PubMed ID: 11027235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.
    Spiga F; Lightman SL; Shekhar A; Lowry CA
    Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.